Signal-dependent protein synthesis by activated platelets: New pathways to altered phenotype and function

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 3, 2008, Pages

  Zimmerman, Guy A ^a   Weyrich, Andrew S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Platelets; Protein synthesis; Proteome; Thrombosis; Transcriptome; Translation

Indexed keywords

MESSENGER RNA; PROTEIN BCL 3; PROTEIN S6; RIBOSOME PROTEIN; THROMBIN; TRANSCRIPTOME; CARRIER PROTEIN; INITIATION FACTOR;

3' UNTRANSLATED REGION; BIOLOGICAL ACTIVITY; CELL ACTIVATION; GENE EXPRESSION; HUMAN; INFLAMMATION; NONHUMAN; PHENOTYPE; POLYSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; ANIMAL; BLOOD CLOT RETRACTION; CELL CULTURE; CYTOLOGY; GENETICS; MEDICAL EDUCATION; METABOLISM; MOUSE; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

ANIMALS; BLOOD PLATELETS; CARRIER PROTEINS; CELLS, CULTURED; CLOT RETRACTION; EDUCATION, MEDICAL, CONTINUING; HUMANS; MICE; PEPTIDE INITIATION FACTORS; PHENOTYPE; PLATELET ACTIVATION; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 40749114795     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.160218     Document Type: Review

References (91)

1. Coller BS. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest. 1997;100:S57- 60.
2. Coller BS. Anti-GPIIb/IIIa drugs: current strategies and future directions. Thromb Haemost. 2001;86:427-443.
3. Freedman JE. Molecular regulation of platelet-dependent thrombosis. Circulation. 2005;112:2725-2734.
4. Bhatt DL, Topol EJ. Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov. 2003;2:15-28.
5. Lindemann S, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Platelet signal-dependent protein synthesis. In: Quinn M, Fitzgerald D, eds. Platelet Function: Assessment, Diagnosis, and Treatment. Totowa, NJ: Humana Press Inc.;2005:149-174.
6. Nachman RL, Jaffe EA. Endothelial cell culture: beginnings of modern vascular biology. J Clin Invest. 2004;114:1037-1040.
7. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest. 1985;76:2003-2011.
8. Zimmerman GA, McIntyre TM, Prescott SM. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest. 1985;76:2235-2246.
9. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527-3561.
10. Herd CM, Page CP. Do platelets have a role as inflammatory cells? In: Joseph M, ed. Immunopharmacology of Platelets. San Diego, CA: Academic Press Inc.;1995:1-20.
11. Klinger MH. Platelets and inflammation. Anat Embryol (Berl). 1997; 196:1-11.
12. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2003;23:2131-2137.
13. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost. 2003;1:1897-1905.
14. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol. 2004;25:489-495.
15. Gawaz M, Langer H, May AE. Platelets in inflammation and athero-genesis. J Clin Invest. 2005;115:3378 -3384.
16. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res. 2007;100:27-40.
17. Weyrich AS, Lindemann S, Tolley ND, Kraiss LW, Dixon DA, Mahoney TM, Prescott SP, McIntyre TM, Zimmerman GA. Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost. 2004;30:491-498.
18. Booyse FM, Rafelson ME Jr. Studies on human platelets. I. Synthesis of platelet protein in a cell-free system. Biochim Biophys Acta. 1968;166: 689-697.
19. Booyse FM, Hoveke TP, Rafelson ME Jr. Studies on human platelets. II. Protein synthetic activity of various platelet populations. Biochim Biophys Acta. 1968;157:660-663.
20. Ts'ao CH. Rough endoplasmic reticulum and ribosomes in blood platelets. Scand J Haematol. 1971;8:134-140.
21. Kieffer N, Guichard J, Farcet JP, Vainchenker W, Breton-Gorius J. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem. 1987;164:189-195.
22. Belloc F, Hourdille P, Boisseau MR, Bernard P. Protein synthesis in human platelets correlation with platelet size. Nouv Rev Fr Hematol. 1982;24:369-373.
23. Pradet-Balade B, Boulmé F, Beug H, Müllner EW, Garcia-Sanz JA. Translation control: bridging the gap between genomics and proteomics? Trends Biochem Sci. 2001;26:225-229.
24. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001;154:485-490.
25. Booyse F, Rafelson ME Jr. In vitro incorporation of amino-acids into the contractile protein of human blood platelets. Nature. 1967;215:283-284.
26. Booyse FM, Rafelson ME Jr. Stable messenger RNA in the synthesis of contractile protein in human platelets. Biochim Biophys Acta. 1967;145: 188-190.
27. Warshaw AL, Laster L, Shulman NR. Protein synthesis by human platelets. J Biol Chem. 1967;242:2094-2097.
28. Booyse FM, Zschocke D, Hoveke TP, Rafelson ME Jr. Studies on human platelets. IV. Protein synthesis in maturing human platelets. Thromb Diath Haemorrh. 1971;26:167-176.
29. Boullin DJ, Votavova M, Green AR. Protein synthesis by human blood platelets after accumulation of leucine and arginine. Thromb Diath Haemorrh. 1972;28:54-64.
30. Steiner M, Baldini M. Protein synthesis in aging blood platelets. Blood. 1969;33:628-633.
31. Plow EF. Extracellular factors influencing the in vitro protein synthesis of platelets. Thromb Haemost. 1979;42:666-678.
32. Newman PJ, Gorski J, White GC II, Gidwitz S, Cretney CJ, Aster RH. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest. 1988;82:739-743.
33. Roth GJ, Hickey MJ, Chung DW, Hickstein DD. Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. Biochem Biophys Res Commun. 1989;160:705-710.
34. Lindemann S, Tolley ND, Eyre JR, Kraiss LW, Mahoney TM, Weyrich AS. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. J Biol Chem. 2001;276:33947-33951.
35. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood. 2003;101:2285-2293.
36. Bugert P, Dugrillon A, Günaydin A, Eichler H, Klüter H. Messenger RNA profiling of human platelets by microarray hybridization. Thromb Haemost. 2003;90:738-748.
37. Fink L, Holschermann H, Kwapiszewska G, Muyal JP, Lengemann B, Bohle RM, Santoso S. Characterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection. Thromb Haemost. 2003;90:749-756.
38. McRedmond JP, Park SD, Reilly DF, Coppinger JA, Maguire PB, Shields DC, Fitzgerald DJ. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics. 2004;3:133-144.
39. Dittrich M, Birschmann I, Pfrang J, Herterich S, Smolenski A, Walter U, Dandekar T. Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell. Thromb Haemost. 2006;95:643-651.
40. Weyrich AS, Zimmerman GA. Evaluating the relevance of the platelet transcriptome. Blood. 2003;102:1550-1551.
41. Poncz M. Platelet message and microarrays. Blood. 2003;101:2078.
42. Semple JW. Platelets give us many messages. Thromb Haemost. 2003; 90:562-563.
43. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, Yost CC, Rubner FJ, Albertine KH, Swoboda KJ, Fratto CM, Tolley E, Kraiss LW, McIntyre TM, Zimmerman GA, Weyrich AS. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005;122:379-391.
44. Schwertz H, Tolley NO, Foulks JM, Denis MM, Risenmay BW, Buerke M, Tilley RE, Rondina MT, Harris EM, Kraiss LW, Mackman N, Zimmerman GA, Weyrich AS. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets. J Exp Med. 2006;203:2433-2440.
45. Rocca B, Secchiero P, Ciabattoni G, Ranelletti FO, Catani L, Guidotti L, Melloni E, Maggiano N, Zauli G, Patrono C. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci U S A. 2002;99:7634-7639.
46. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation. 2006;113:2278-2284.
47. Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol. 2005;6:318-327.
48. Rosenwald IB, Pechet L, Han A, Lu L, Pihan G, Woda B, Chen JJ, Szymanski I. Expression of translation initiation factors elF-4E and elF-2alpha and a potential physiologic role of continuous protein synthesis in human platelets. Thromb Haemost. 2001;85:142-151.
49. Raught B, Gingras AC, Sonenberg N. The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A. 2001;98:7037-7044.
50. Tee AR, Blenis J. mTOR, translational control and human disease. Semin Cell Dev Biol. 2005;16:29-37.
51. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95-105.
52. Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM, Zimmerman GA. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A. 1998;95: 5556-5561.
53. Weyrich AS, Denis MM, Schwertz H, Tolley ND, Foulks J, Spencer E, Kraiss LW, Albertine KH, McIntyre TM, Zimmerman GA mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood. 2007;109:1975-1983.
54. Papkoff J, Chen RH, Blenis J, Forsman J. p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol Cell Biol. 1994;14:463-472.
55. Schalm SS, Blenis J. Identification of a conserved motif required for mTOR signaling. Curr Biol. 2002;12:632-639.
56. Brown EJ, Schreiber SL. A signaling pathway to translational control. Cell. 1996;86:517-520.
57. Conne B, Stutz A, Vassalli JD. The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat Med. 2000;6:637-641.
58. Mazumder B, Seshadri V, Fox PL. Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci. 2003;28:91-98.
59. Brewer G. Misregulated posttranscriptional checkpoints: inflammation and tumorigenesis. J Exp Med. 2001;193:F1-F4.
60. Dixon DA, Tolley ND, Bemis-Standoli K, Martinez ML, Weyrich AS, Morrow JD, Prescott SM, Zimmerman GA. Expression of COX-2 in plate-let-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest. 2006;116:2727-2738.
61. Houng AK, Maggini L, Clement CY, Reed GL. Identification and structure of activated-platelet protein-1, a protein with RNA-binding domain motifs that is expressed by activated platelets. Eur J Biochem. 1997;243:209-218.
62. Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation. 2001;103:1718-1720.
63. Pabla R, Weyrich AS, Dixon DA, Bray PF, McIntyre TM, Prescott SM, Zimmerman GA. Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J Cell Biol. 1999;144:175-184.
64. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 1996; 97:1525-1534.
65. Weyrich AS, Denis MM, Kuhlmann-Eyre JR, Spencer ED, Dixon DA, Marathe GK, McIntyre TM, Zimmerman GA, Prescott SM. Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates. Circulation. 2005;111:633-642.
66. Lindemann SW, Weyrich AS, Zimmerman GA. Signaling to translational control pathways: diversity in gene regulation in inflammatory and vascular cells. Trends Cardiovasc Med. 2005;15:9-17.
67. Schubert S, Focke B, Carter J, Schlitt A, Russ M, Pressek P, Sibelius U, Grandel F, Seeger W, Werdan K, Buerke M. A study of platelet activation by bacterial toxins. The FASEB Journal. 2007;21:864.3.
68. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol. 1995;11: 549-599.
69. Mahoney TS, Weyrich AS, Dixon DA, McIntyre T, Prescott SM, Zimmerman GA. Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes. Proc Natl Acad Sci U S A. 2001;98:10284-10289.
70. Lindemann SW, Yost CC, Denis MM, McIntyre TM, Weyrich AS, Zimmerman GA. Neutrophils alter the inflammatory milieu by signaldependent translation of constitutive messenger RNAs. Proc Natl Acad Sci U S A. 2004;101:7076-7081.
71. Yost CC, Denis MM, Lindemann S, Rubner FJ, Marathe GK, Buerke M, McIntyre TM, Weyrich AS, Zimmerman GA. Activated polymorphonuclear leukocytes rapidly synthesize retinoic acid receptor-alpha: a mechanism for translational control of transcriptional events. J Exp Med. 2004;200:671-680.
72. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124:471-484.
73. Franzoso G, Carlson L, Scharton-Kersten T, Shores EW, Epstein S, Grinberg A, Tran T, Shacter E, Leonardi A, Anver M, Love P, Sher A, Siebenlist U. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity. 1997;6:479-490.
74. Parise LV, Smyth SS, Shet A, Coller BS. Platelet morphology, biochemistry, and function. In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT, eds. Williams Hematology. 7th ed. New York, NY: McGraw-Hill 2006:1597-1645.
75. Berndt MC, Andrews R. Comment on Weyrich AS et al, page 1975: Full clot retraction: running on mTOR. Blood. 2007;109:1791-1792.
76. Palmerini T, Nedelman MA, Scudder LE, Nakada MT, Jordan RE, Smyth S, Gordon RE, Fallon JT, Coller BS. Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates. J Am Coll Cardiol. 2002;40:360-366.
77. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002;22:1769-1776.
78. Dever TE. Gene-specific regulation by general translation factors. Cell. 2002;108:545-556.
79. Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER. Activated platelets express IL-1 activity. J Immunol. 1989;143:4015-4018.
80. Hawrylowicz CM, Howells GL, Feldmann M. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med. 1991;174:785-790.
81. Kaplanski G, Porat R, Aiura K, Erban JK, Gelfand JA, Dinarello CA. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood. 1993;81:2492-2495.
82. Loppnow H, Bil R, Hirt S, Schönbeck U, Herzberg M, Werdan K, Rietschel ET, Brandt E, Flad HD. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood. 1998;91:134-141.
83. Pillitteri D, Bassus S, Boller K, Mahnel R, Scholz T, Westrup D, Wegert W, Kirchmaier CM. Thrombin-induced interleukin 1beta synthesis in platelet suspensions: impact of contaminating leukocytes. Platelets. 2007; 18:119-127.
84. Panes O, Matus V, Sáez CG, Quiroga T, Pereira J, Mezzano D. Human platelets synthesize and express functional tissue factor. Blood. 2007;109: 5242-5250.
85. Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood. 2004;104:3943-3948.
86. Franscini N, Bachli EB, Blau N, Fischler M, Walter RB, Schaffner A, Schoedon G. Functional tetrahydrobiopterin synthesis in human platelets. Circulation. 2004;110:186-192.
87. Evangelista V, Manarini S, Di Santo A, Capone ML, Ricciotti E, Di Francesco L, Tacconelli S, Sacchetti A, D'Angelo S, Scilimati A, Sciulli MG, Patrignani P. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res. 2006;98:593-595.
88. Savini I, Catani MV, Arnone R, Rossi A, Frega G, Del Principe D, Avigliano L. Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic Biol Med. 2007;42:608-616.
89. Meshorer E, Misteli T. Splicing misplaced. Cell. 2005;122:317-318.
90. Huang YS, Richter JD. Regulation of local mRNA translation. Curr Opin Cell Biol. 2004;16:308-313.
91. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA. Short RNAs repress translation after initiation in mammalian cells. Mol Cell. 2006;21: 533-542.